Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RALGAPA2 encodes the catalytic subunit alpha 2 of the heterodimeric Ral GTPase Activating Protein (RalGAP) complex, which functions as a GTPase activator for Ras-like small GTPases RALA and RALB. It plays a regulatory role in the localization of exocyst components and protein localization within cells. Mutations in RALGAPA2 are associated with Ohdo syndrome (SBBYS variant), but it is not a direct therapeutic target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ral GTPase activating protein catalytic subunit alpha 2 (RALGAPA2).